Regulatory News
US FDA Commissioner Blogs about Improving the Integrity of the Drug Supply Chain
Rx-360 Summary of US House of Representatives Draft Bill to Prevent Drug Shortages by Amending the Food, Drug and Cosmetic Act
Rx-360 Summary of Programme to rationalise international GMP inspections of active pharmaceutical ingredients/active substances manufacturers
FDA Issues Cut Label Final Rule
Rx-360 Summary of PIC/S Recommended Model for Risk-Based Inspection Planning in the GMP Environment
Rx-360 Summary of the US FDA Draft Guidance for Industry, Notification to FDA of Issues that May Result in a Prescription Drug or Biological Product Shortage
Rx-360 Summary of the GAO Supply Chain Security Report – February 2012
Rx-360 Summary of the Proposed USP Chapter 1083 Concerning Supply Chain Integrity
Rx-360 Summary of EC Concept Paper for Importing APIs
Rx-360 Summary of the FDA Interim Final Rule on Product Discontinuance
Rx-360 Summary of US S-1886 Counterfeit Penalty Act
To read all legislative and regulatory summaries created by Rx-360 click here